LAV
lavfund.com
Actively hiring
Biotechnology
Venture Capital
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Portfolio
Companies
79
5 of them startups
Hiring now
2
companies with open roles
Rounds in 12 months
1
$21.5M raised
Its companies, the freshest money firstAll in Startups
InhibrxVenture round $200M · 3 yr ago
Perfuse TherapeuticsVenture round $9M · 6 yr ago
Legend Biotech39 roles
Crown Bioscience17 roles
Innoventbio
CanSino Biologics Inc.
All Reserved Banquansuoyou Lupengzhiyaoyouxiangongsi YueICPbei 2021073146hao Document
Insilico
Abbisko Therapeutics Co., Ltd.
2026 MicroTech Medical, Inc.
Inventisbio
Dizal Pharma
Airdoc
Outlook
Jacobiopharma
Gracell Biotechnologies Inc.
ArriVent BioPharma
KSQ Therapeutics
Banquansuoyou Beidayaoyegufenyouxiangongsi (zhe)-feijingyingxing-2023-0062 ZheICPbei11052940hao-2 Wangzhanchitu
Sonoma Biotherapeutics
Overview
LAV, formerly Lilly Asia Ventures, is a life sciences venture capital firm investing in biotechnology and healthcare companies in China and the United States. It backs companies from early stage through growth, spanning innovative drugs, biologics, medical devices, diagnostics and healthcare services. Founded in 2008 by Yi Shi with Eli Lilly as its original sponsor, LAV now operates independently and is headquartered in Shanghai with offices in Hong Kong and the United States.
Offices
Where the company hires and what each office is for
Cities
2
Hiring now
0
Countries
2
Loading the map
Headquarters
Builds here
Office with open vacancies
No open vacancies right now Tap a pin for the office
Shanghai
China
HQ
Hong Kong
Hong Kong
Regional office
Our Philosophy
Room 606-7, St George's Building, 2 Ice House Street, Central, Hong Kong